EV-SELEX speeds GPCR drug discovery by capturing receptor-bound DNA… | HappeningNow.news

Science · 20 views

EV-SELEX speeds GPCR drug discovery by capturing receptor-bound DNA aptamers

G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, regulating diverse physiological processes ranging from pain perception to hormone signaling.

Source AI Summary Published July 7, 2026 Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 20 Community interest
Brief read Under 1 min brief 92 words

AI Summary

Researchers have developed a new method for accelerating the discovery of drugs targeting G protein-coupled receptors (GPCRs). This approach, known as EV-SELEX, involves capturing DNA aptamers that bind to GPCRs. The significance of this development lies in the central role GPCRs play in regulating various physiological processes. As the most abundantly expressed proteins in the human body, they are a primary target for many new drugs in development. This method may streamline the process of identifying potential drug candidates, potentially leading to more efficient development of treatments for a range of conditions.

AI summaries can be wrong sometimes—always verify important details using the source article.

How AI & Automation are used
Read original at PHYS

More from Science

Continue reading recent Science coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page